Rabies Virus Explained — Nearly 100% Fatal, Almost 100% Preventable

Photo: Monstera Production / Pexels
Rabies is the most lethal infection known to medicine once symptoms begin, and one of the easiest to stop before they do. The virus enters through a bite or scratch, climbs the nerves toward the brain, and by the time a person feels ill it is already inside the central nervous system, out of reach of antibodies and drugs. Yet wound washing, vaccine, and immune globulin given in time prevent the disease almost every time. This article explains how rabies virus works, why timing decides everything, and where it still kills.
Educational content, not medical advice. This article summarizes public-health guidance from the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). Anyone who may have been exposed to a potentially rabid animal should contact a doctor or the local health department right away, because only a clinician can assess an individual exposure.
What the rabies virus is and how it is built
Rabies virus is a negative-strand RNA virus (its genetic code is written as the mirror image of a message, so the cell cannot read it directly) in the family Rhabdoviridae and the genus Lyssavirus (Gluska et al., PLoS Pathogens, 2014). Under an electron microscope the particle looks like a short bullet. In the imaging study cited here, virions measured roughly 100 by 200 nanometers.
The outer envelope carries a protein called the glycoprotein (G), which does the job of a key. It binds receptors on nerve cells and fuses the viral envelope with the cell's membrane so the virus can get inside. Several receptors have been implicated, including the neural cell adhesion molecule (NCAM) and the p75 neurotrophin receptor (p75NTR) (Gluska et al.). Because nerve cells are the target, rabies is called a neurotropic virus.
The genus Lyssavirus includes more than one species. The International Committee on Taxonomy of Viruses recognizes well over a dozen lyssavirus species, and several related bat viruses are still awaiting formal classification. Classical rabies virus accounts for nearly all human disease. Other lyssaviruses, such as Duvenhage virus, Mokola virus, and Australian bat lyssavirus, cause rare cases in particular regions.
For the general mechanics of how viruses enter cells and copy themselves, see our guide to how viruses work. Rabies departs from the usual pattern in one respect: it is not especially fast or especially destructive to cells. Its lethality comes from where it replicates, not how hard it hits.
Where rabies lives: dogs, bats, and wildlife
Rabies circulates in mammals. Birds, reptiles, and amphibians do not carry it. Which animal matters most depends on geography, and the difference explains why a rabies death in Delhi and one in Idaho look nothing alike.
| Region or setting | Main source of human cases | Evidence |
|---|---|---|
| Asia and Africa | Dogs | Dog bites and scratches cause up to 99% of human cases worldwide (WHO) |
| Americas, where dog rabies is mostly controlled | Bats, including blood-feeding bats | WHO identifies bats as the main source of human cases there |
| United States | Bats | At least 7 in 10 U.S. rabies deaths followed infection from bats (CDC) |
| United States, animals | Wildlife | More than 90% of reported animal rabies cases occur in wildlife (CDC) |
Sources: WHO rabies fact sheet; CDC, About Rabies.
The CDC reports that nearly three in four Americans live in a community where animals carry rabies, and that wildlife professionals distribute more than 5 million oral vaccine baits each year to immunize wild animals. Veterinarians vaccinate more than 90 million cats and dogs annually. That layered defense, pets vaccinated and wildlife baited, is the reason human rabies is rare in the United States even though the virus is still circulating in bats and other wild mammals.
Not every bite carries the same risk. Whether a bite transmits rabies depends on whether the animal is infected, how much virus its saliva carries at that moment, how deep the wound is, and how close it is to the head and the dense nerve supply of the face and hands. Those variables are why exposure guidance is built around categories rather than a single rule.
How rabies climbs from a bite to the brain
The best way to picture rabies is as a courier that avoids the highway. The immune system patrols the bloodstream and tissues like a police force watching the roads. Rabies virus leaves the roads almost immediately and takes the nerve's own underground railway to the brain.
- Entry. The virus is in the saliva of an infected animal. It enters through a bite or scratch that breaks the skin, or through mucous membranes such as the eyes, nose, or mouth.
- Local replication. In many cases the virus first multiplies in muscle near the wound. This can take days to weeks, and it is one reason incubation varies so widely.
- Docking on nerves. The glycoprotein binds receptors on the endings of peripheral nerves, and the virus is taken up into the nerve cell.
- Retrograde transport. Inside the long, thin extension of a nerve cell (the axon), the virus rides the cell's own molecular transport system backward, toward the cell body and the spinal cord. Nerve cells run a two-way cargo service: kinesin motors carry material outward and dynein motors carry it inward. Rabies hitches a ride on the inbound line.
- Spread through the central nervous system. Once it reaches the spinal cord and brain, the virus replicates extensively and spreads between connected neurons.
- Outward spread. From the brain the virus travels back out along nerves to many tissues, including the salivary glands, where it enters saliva and becomes available to infect the next host.
How fast does the virus travel inside a nerve?
A 2014 imaging study tracked individual rabies particles inside cultured nerve cells from the dorsal root ganglia (clusters of sensory neurons near the spine). Particles that traveled together with the p75NTR receptor moved at an average of about 0.86 micrometers per second, and the overall average for rabies particles was 0.93 micrometers per second, roughly 40 percent faster than nerve growth factor, a natural cargo of the same pathway (Gluska et al., 2014). Converted, 0.93 micrometers per second is about 80 millimeters per day.
That figure comes from cultured cells, not from a living person, and measurements of transport speed in animals vary, so it should be read as a measure of the transport machinery rather than a prediction of how fast any real infection advances. As an illustration only, a path of one meter at 80 millimeters per day would take about 12 days. Real incubation periods run far longer, which suggests that travel along the axon is only one part of the delay, alongside local replication and the time the virus spends at each stage.
Why can't the immune system stop rabies?
By the time rabies enters a nerve, it has left the places where antibodies and most immune cells operate. Antibodies circulate in blood and tissue fluid, and once the virus is inside a nerve cell it is largely out of their reach. The Lancet Neurology review cited below describes a weak immune response inside the central nervous system, especially in furious rabies. The practical consequence is that treatment has to reach the virus before it reaches the nerve, which is the whole logic of post-exposure prophylaxis.
How long is the incubation period?
WHO states that the incubation period is typically two to three months but can range from one week to one year (WHO). The CDC describes it as weeks to months. The interval depends on the location and severity of the wound and the amount of virus introduced. That wide window is the opportunity: treatment started during incubation can stop the virus before it reaches the central nervous system.
What rabies symptoms look like and why they signal near-certain death
Early rabies resembles many other illnesses. The CDC lists weakness, fever, and headache, often with discomfort, prickling, or itching at the bite site, which may last for several days. Severe disease usually follows within about two weeks of the first symptoms, with anxiety, confusion, agitation, hallucinations, excessive saliva, fear of fluids despite thirst, and aggressive behavior.
Furious and paralytic rabies
There are two clinical forms. In furious rabies, the more familiar form, the person becomes hyperactive and agitated. Hydrophobia (fear of water) and aerophobia (fear of air or drafts) are hallmarks, and the CDC describes a fear of fluids despite thirst. WHO says death usually follows within a few days from cardio-respiratory arrest.
Paralytic rabies accounts for about 20 percent of human cases, according to WHO. It begins with paralysis at the wound site that spreads, progressing to coma and death. Because it lacks the dramatic excitement of the furious form, it is often misdiagnosed. A 2013 review in The Lancet Neurology found that patients with the furious form survive for less time than those with the paralytic form, which fits a higher viral load and weaker immune response in the central nervous system in furious cases (Hemachudha et al., 2013). The same review notes that the virus is in the central nervous system well before symptoms start.
No test, no cure after symptoms
WHO states that no approved tool detects rabies infection before clinical onset, and that diagnosis without a reliable exposure history or specific symptoms is difficult. Confirmation usually comes after death from samples of brain, skin, or saliva. By the time the disease announces itself, the virus is established in the brain, and treatment is typically supportive. WHO describes the disease as virtually 100 percent fatal once symptoms appear, with very rare survivors who often have severe neurological deficits.
What happened to the Milwaukee protocol?
In 2004 a 15-year-old in Wisconsin survived rabies after an experimental regimen of induced coma and antiviral drugs, later called the Milwaukee protocol. It raised hopes for a treatment. A 2025 viewpoint in Clinical Infectious Diseases concluded that the protocol has not been shown to work: no detailed report since the original case has documented efficacy, at least 64 failures have been reported, and about 34 well-documented survivors exist worldwide, many with serious neurological damage, with some recovering on intensive care alone (Jackson, 2025). The author calls for abandoning the protocol. Survival after symptoms remains an exception, not a treatment.
How post-exposure prophylaxis stops rabies before the brain
The long incubation period creates a race, and post-exposure prophylaxis (PEP) is built to win it. PEP has three parts that work on different timescales: cleaning the wound, a quick dose of ready-made antibodies, and a vaccine that teaches the body to make its own.
An analogy helps. Think of the virus as an intruder who has entered the building's ground floor but has not yet reached the vault. Washing the wound removes intruders at the door. Immune globulin posts temporary guards immediately. The vaccine trains a permanent security team, but training takes about a week or two, so the guards must hold the line meanwhile.
Step one: wash the wound
WHO guidance is to wash the wound with soap and water for at least 15 minutes and then seek medical care. The U.S. state health summary of CDC recommendations adds a virucidal agent such as povidone-iodine for irrigation if available. This step costs nothing and starts working immediately.
Step two: exposure categories decide what else is needed
WHO classifies exposures by severity, and the category determines treatment.
| WHO category | What happened | Recommended response |
|---|---|---|
| I | Touching or feeding animals, or licks on intact skin | Wash the skin; no PEP |
| II | Nibbling of uncovered skin, or minor scratches or abrasions without bleeding | Wash the wound and vaccinate immediately |
| III | Single or multiple bites or scratches that break the skin, contamination of mucous membranes, or direct contact with bats | Wash the wound, vaccinate immediately, and give immunoglobulin or monoclonal antibodies |
Source: WHO rabies fact sheet.
Step three: antibodies now, vaccine for lasting protection
Rabies immune globulin (RIG) is a preparation of antibodies that neutralizes virus at the wound immediately. WHO notes that monoclonal antibodies can be used in place of immunoglobulin where indicated. In the CDC-aligned U.S. schedule, human rabies immune globulin is given once, on day 0, at 20 international units per kilogram of body weight. As much as is anatomically feasible is infiltrated into and around the wound, and any remainder is given by intramuscular injection at a site away from the vaccine.
The vaccine is a course of injections that prompts the immune system to produce its own antibodies. The U.S. schedule for people who have never been vaccinated and have normal immune function is four 1.0 mL intramuscular doses on days 0, 3, 7, and 14, with a fifth dose on day 28 possible for immunocompromised people (West Virginia Bureau for Public Health summary of CDC and ACIP recommendations, revised May 31, 2022).
| Situation | Immune globulin | Vaccine doses |
|---|---|---|
| Never vaccinated, normal immunity | One dose on day 0 | Four doses: days 0, 3, 7, and 14 |
| Never vaccinated, weakened immunity | One dose on day 0 | Five doses: days 0, 3, 7, 14, and 28, plus antibody testing afterward |
| Previously vaccinated with documented response | None | Two doses: days 0 and 3 |
Source: West Virginia Bureau for Public Health, Summary of Rabies Post-Exposure Prophylaxis Recommendations, 2022.
Immune globulin has a time limit that follows the same logic as the analogy. If it was not given when vaccination began, it can still be given through day seven. After that, the guidance says it is not indicated because the person is presumed to have started making antibodies.
How well does PEP work?
The CDC states that PEP is nearly 100 percent effective if started after exposure and before symptoms. Its guidance also stresses that this holds only when the full regimen is completed, and that any deviation from the schedule calls for expert consultation. PEP does not work after symptoms start, which is why the decision cannot wait for a wound to "look infected."
The CDC reports that about 100,000 Americans receive vaccination after a potential exposure each year. WHO says more than 29 million people worldwide receive a human rabies vaccine annually, and that the average cost of a PEP course was US$108 as of 2018, not counting travel and lost income. Giving the vaccine into the skin (intradermally) in small doses can cut costs by 60 to 80 percent compared with intramuscular injection without compromising safety or efficacy, according to WHO.
Pre-exposure vaccination
People with a continuing risk of exposure, such as veterinary staff, animal handlers, and laboratory workers, can be vaccinated before any exposure. The schedule and any antibody checks or boosters depend on the risk group and current CDC guidance. Pre-exposure vaccination does not remove the need for medical assessment after a bite, but it simplifies what comes next: previously vaccinated people with documented immunity need two vaccine doses and no immune globulin.
Bats, travel, and the United States numbers
Rabies is rare in the United States, with fewer than 10 deaths reported each year according to the CDC. Bats are the main source of those deaths. The unusual feature of bat exposure is that it is easy to miss. The CDC's guidance covers contact "even through clothing or without visible bite or scratch marks," because a person who was asleep, or a child too young to report what happened, may not know a bite occurred.
The CDC's January 2022 release on human rabies illustrates the pattern. Three people died of rabies between late September and early November 2021, one each in Idaho, Illinois, and Texas, and one was a child. The total for 2021 reached five cases, compared with none reported in 2019 or 2020. All three bat-linked patients had direct contact with bats in or around their homes, and none received PEP. Two exposures were judged avoidable: one involved a bat roost in the home, and in the other the person picked up a bat with bare hands. Two patients released the bat rather than having it captured for testing (CDC release).
That last detail matters. A bat that can be caught and tested gives public-health staff something concrete to act on. A bat that flies away leaves the question open, and clinicians then have to weigh the possibility of exposure without that information. The CDC advises people who may have had contact with a bat, even through clothing or without a visible wound, to call their state or local health department or animal control and to contact a doctor or public health official to determine whether PEP is needed.
Travel also matters. Because dog-mediated rabies remains common in parts of Asia and Africa, a bite abroad can be a high-risk event even for someone who lives in a country where the disease is rare. The CDC reports that more than 80 people in the United States have died of rabies acquired during travel since 1990.
How many people rabies kills, and why estimates differ
Nobody counts rabies deaths precisely. Most deaths occur in rural areas where patients die at home without a laboratory diagnosis, and many are recorded as encephalitis or simply as unexplained fever. Researchers therefore model the burden from dog-bite data, rates of infection after bites, and the use of PEP.
| Estimate | Deaths per year | Source and date |
|---|---|---|
| Modeled burden of endemic canine rabies | About 59,000 (with a wide uncertainty range) | Hampson et al., PLoS Neglected Tropical Diseases, 2015 |
| WHO Global Health Estimates | 44,203 | WHO fact sheet, citing 2021 estimates; WHO says likely an undercount |
| CDC statement on global burden | More than 95% of an estimated 70,000 deaths caused by dogs | CDC, About Rabies |
Sources: Hampson et al. 2015 summary, University of Glasgow; WHO; CDC.
The numbers differ because they come from different methods and different years, and the 2015 model carried a wide uncertainty range. The consistent message across them is the distribution. Rabies is mainly a disease of Asia and Africa. WHO says children under 15 account for 40 percent of deaths. The 2015 model estimated that India alone has more than 20,000 deaths annually and put the economic cost at about US$8.6 billion per year, a figure WHO also cites. Most of that cost came from premature deaths, with the rest from vaccine spending, lost income while seeking treatment, and other costs.
Why eliminating dog-mediated rabies is possible
Because dogs cause nearly all human cases, the most effective way to prevent human rabies is to vaccinate dogs. WHO states that mass dog vaccination is the most cost-effective prevention strategy and that culling free-roaming dogs is not effective. The global strategic plan known as Zero by 30 aims to end human deaths from dog-mediated rabies by 2030.
There is evidence it can be done. WHO reports that Bhutan, Chile, and Mexico have been validated as having eliminated dog-mediated human rabies as a public health problem, and that 17 countries have declared themselves free of rabies virus infection to the World Organisation for Animal Health (an animal-health status, not the same thing). Chile, validated in 2026 as the first South American country and the third in the world, built its result on mass free vaccination of dogs and cats begun in the 1960s, surveillance, laboratory confirmation, rapid response to detected cases, and timely PEP. Its last human case linked to the canine variant was recorded in 1972. The Pan American Health Organization (PAHO) stresses that elimination of dog-mediated rabies is not eradication: virus still circulates in wildlife, especially bats, so surveillance must continue (PAHO).
That distinction explains why two very different public-health problems share one name. Where dogs are the reservoir, rabies is a solvable vaccination and access problem. Where bats are the reservoir, it becomes a problem of awareness and quick decisions after contact, because a bat reservoir cannot be vaccinated away in the same way.
A short history: Pasteur's treatment in 1885
Louis Pasteur's laboratory produced the first widely recognized rabies treatment. In the summer of 1885, nine-year-old Joseph Meister was brought to Pasteur after being bitten by a dog, reportedly 14 times. Pasteur judged death almost certain. He gave the boy daily injections of spinal cord from infected rabbits, starting with the driest and least virulent preparation and moving to the freshest and most virulent. Meister never developed symptoms, and Pasteur became an international celebrity (Science History Institute).
The episode is also a reminder of how experimental the treatment was. The same account notes that infection can only be confirmed once symptoms appear and that the vaccine had not been fully tested even in animals. Modern vaccines are made and tested very differently. For the broader story of how Pasteur's work fits with the germ theory, see our explainer on Pasteur and Koch and our profile of Louis Pasteur.
What people get wrong about rabies
Only a bite can transmit it. Bites are the main route, but WHO's Category II and III definitions include scratches and mucous-membrane contamination. Saliva reaching the eyes, nose, or mouth counts as exposure.
Every rabies patient becomes violent. The furious form is the familiar one, but about 20 percent of human cases are paralytic, according to WHO. These patients progress from paralysis to coma without dramatic agitation, and the disease is often misdiagnosed.
Hydrophobia is an ordinary fear of water. It is a symptom of advanced disease, not a psychological quirk. The CDC lists fear of fluids despite thirst among the signs of advanced illness, along with excessive saliva, agitation, and hallucinations.
Rabies is everywhere in the United States. The virus circulates in wildlife, but human cases are rare because of pet vaccination, wildlife baiting, and PEP. The risk is real but concentrated in specific situations, notably contact with bats.
If a wound has healed, nothing can be done. WHO guidance is to treat as soon as possible after exposure. The incubation period can last months, and PEP works as long as symptoms have not started. Delay increases risk, but the decision to seek care is sound even weeks later, and a clinician can advise on timing.
Rabies is a purely historical disease. It still kills tens of thousands of people each year, according to WHO's own estimate, and most deaths are preventable with vaccines and antibodies that exist today.
How rabies compares with other infections that attack the nervous system
Rabies is not the only pathogen that damages the nervous system, but it is unusual in how completely the outcome is decided before symptoms appear. Our explainers on prions, poliovirus, and West Nile virus cover other routes to the same organ, each with its own biology. Rabies stands out as a disease with a long silent period during which a highly effective intervention exists, followed by a stage with essentially none.
Our related virus coverage includes the H5N1 bird flu guide, the Ebola explainer, and the HIV guide. For how vaccines build the lasting protection that rabies PEP relies on, see how vaccines work and how antibodies are structured. For how bats, the main U.S. reservoir, fit into the wider pattern of animal-to-human spread, see our piece on how viruses jump from animals to humans.
Frequently asked questions
Q: Is rabies always fatal? A: Once clinical symptoms appear, WHO describes rabies as virtually 100 percent fatal. A small number of survivors have been documented, about 34 worldwide by one 2025 review, and many have severe neurological damage. Before symptoms, prompt post-exposure prophylaxis prevents the disease in nearly all cases.
Q: How long is the incubation period? A: WHO says it is typically two to three months and can range from one week to one year. The CDC describes it as weeks to months. The length depends on the wound location, severity, and amount of virus introduced.
Q: What does post-exposure prophylaxis consist of? A: Thorough wound washing with soap and water for at least 15 minutes, a course of rabies vaccine, and, for severe exposures such as Category III, rabies immune globulin or monoclonal antibodies. In the U.S. schedule for people not previously vaccinated, the vaccine is given on days 0, 3, 7, and 14.
Q: Why is a bat in the bedroom treated as a possible exposure? A: Bat bites can be small and unnoticed, particularly in a sleeping person or a young child. The CDC says that anyone who may have had contact with a bat, even without a visible bite, should contact the local health department or a doctor to determine whether PEP is needed, and the bat should be captured for testing if that can be done safely.
Q: Can rabies be caught from a pet that has been vaccinated? A: A vaccinated pet is much less likely to be infected, and mass dog vaccination is the reason dog-mediated rabies has been eliminated as a public health problem in places such as Mexico, Bhutan, and Chile. Whether PEP is needed after a particular bite is decided case by case by clinicians and health authorities, who weigh the animal's status and the nature of the exposure.
Q: Why can't antibiotics or antivirals treat rabies? A: Rabies is a viral infection, so antibiotics do not act on it, and no antiviral has been shown to cure established disease. After symptoms begin, treatment is supportive. The 2025 review of the Milwaukee protocol found no evidence that the experimental regimen works.
Q: How many people die from rabies each year? A: WHO's estimate based on 2021 data is 44,203 deaths, likely an undercount. An earlier 2015 model estimated about 59,000. Both place the burden mainly in Asia and Africa, with dogs responsible for up to 99 percent of human cases and children under 15 accounting for 40 percent of deaths.
The takeaway
Rabies is an unusual case in medicine because the outcome is decided during a quiet window that most people never notice. For weeks or months the virus is inching up a nerve, invisible to the immune system, and a combination of soap, antibodies, and vaccine can stop it. After the window closes, nothing reliable can. The cost of that asymmetry falls on the places where PEP is hard to reach and dogs are unvaccinated, which is why 44,203 deaths in 2021, by WHO's count, is a problem of access, not of biology. Where dog vaccination and PEP are in place, as in Mexico, Bhutan, and Chile, the disease stops being a public health problem for people.
Sources
- WHO, Rabies fact sheet
- CDC, About Rabies
- CDC, Human rabies cases in the United States, 2021 (archived release, January 2022)
- West Virginia Bureau for Public Health, Summary of Rabies Post-Exposure Prophylaxis Recommendations (rev. May 31, 2022)
- Hampson K, et al. Estimating the global burden of endemic canine rabies. PLoS Neglected Tropical Diseases, 2015 (summary, University of Glasgow)
- Hemachudha T, et al. Human rabies: neuropathogenesis, diagnosis, and management. The Lancet Neurology, 2013
- Gluska S, et al. Rabies virus hijacks and accelerates the p75NTR retrograde axonal transport machinery. PLoS Pathogens, 2014
- Jackson AC. Demise of the Milwaukee protocol for rabies. Clinical Infectious Diseases, 2025
- Science History Institute, Biting Back (Pasteur's rabies treatment)
Read next:
Follow new articles
Add SciHub101 to your feed reader to see new science and technology stories.
About the Author
SciHub101 is an independent science and technology publication founded and edited by Buğra Sözeri, a software engineer and app developer based in Türkiye. AI tools assist with drafting and research. Source documentation in the existing archive is uneven, and articles are being reviewed and corrected. The Editorial Team byline identifies editorial responsibility; it does not certify specialist or independent human review. Where we compare products, anything built by our own team is labelled as such — see the editorial guidelines and About page for how corrections and disclosures work.
Related Articles

Dengue Virus Explained — Why It's Spreading and How It Works
How the four dengue serotypes infect cells, why a second infection can be worse, what WHO data show about the 2024 record year, and where dengue vaccines stand.

Hepatitis B and C Explained — How They Damage the Liver
Hepatitis B and C explained: how each virus infects liver cells, why HCV is curable in 8 to 12 weeks, and why HBV is suppressed but not yet cured.

HPV Explained — How the Virus Causes Cancer and How the Vaccine Works
How HPV infects cells, how E6 and E7 proteins drive cervical and throat cancers, why most infections clear, and what vaccination and screening data show.

RSV Explained — How Respiratory Syncytial Virus Works
RSV explained: how respiratory syncytial virus infects airways, why it hits infants and older adults hard, and how new vaccines and antibodies work.

Measles Virus Explained — Why It's Coming Back in 2026
How measles spreads, why it erases immune memory, what the MMR vaccine does, and why cases are rising, with 2024-2026 data from WHO, CDC, and PAHO.

Influenza Virus Explained — How Seasonal Flu Actually Works
Influenza virus explained: how flu infects cells, why it drifts and shifts, how vaccines are chosen, and why effectiveness swings from season to season.